{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:34:44Z","timestamp":1792823684683,"version":"4.5.0"},"reference-count":94,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019186","name":"HORIZON EUROPE Innovative Europe","doi-asserted-by":"publisher","award":["101103076"],"award-info":[{"award-number":["101103076"]}],"id":[{"id":"10.13039\/100019186","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosdigitalhealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Digit Health"],"abstract":"<jats:p>\n                    Regions within eastern and southern Africa (SE-Africa) carry some of the highest malaria burdens. Understanding the spatiotemporal dynamics of the emergence and spread of artemisinin (partial) resistance (ART-R) and how to mitigate ART-R is therefore of paramount importance in these areas. Here, we present a dashboard developed by the Mitigating Antimalarial Resistance Consortium for SE-Africa in collaboration with nineteen national control malaria programs (NCMPs) and their partners. The dashboard supports NCMPs\u2019 decision-making by providing curated information on the latest available antimalarial resistance data. We systematically reviewed, collated, and visualized antimalarial resistance information from therapeutic efficacy studies, molecular surveillance for\n                    <jats:italic>Pfkelch13<\/jats:italic>\n                    ART-R genetic markers, current in-country malaria treatment policies, and reported malaria cases and deaths. We identified evidence gaps in therapeutic efficacy and molecular surveillance, particularly in southern Africa. Five countries, Angola, the Democratic Republic of Congo, Kenya, Tanzania and Uganda, reported artemether-lumefantrine treatment failures above the WHO threshold of 10% after correcting for reinfections. The A675V, R561H, P574L, and C469F\n                    <jats:italic>Pfkelch13<\/jats:italic>\n                    markers were highly prevalent in cross-border regions of several East African countries, with the C469Y marker rapidly spreading across Uganda. The dashboard provides an interactive platform for sharing regional data. We discuss the implications of these findings for policy, practice, and research.\n                  <\/jats:p>","DOI":"10.1371\/journal.pdig.0000743","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:36:07Z","timestamp":1778088967000},"page":"e0000743","update-policy":"https:\/\/doi.org\/10.1371\/journal.pdig.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["The MARC SE-Africa dashboard: Joining forces to counteract emerging antimalarial resistance in South and East Africa"],"prefix":"10.1371","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2655-8518","authenticated-orcid":true,"given":"Stephanie","family":"van Wyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishen","family":"Seocharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulambius M.","family":"Mlugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhol S.","family":"Ayuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donnie","family":"Mategula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tikhala","family":"Makhaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kiarie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-4692","authenticated-orcid":true,"given":"Victor","family":"Asua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Opigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimable","family":"Mbituyumuremyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kibor Kipkemoi","family":"Keitany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmah Mongina","family":"Nyandigisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sinarinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Aguek","family":"Kon Baak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy Nseka","family":"Manbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samwel Lazaro","family":"Nhiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijenunu Aron","family":"Mwaikambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maulid","family":"Kassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sija Joseph","family":"Sija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdikarin Hussein","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Katende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0728-3093","authenticated-orcid":true,"given":"Jaishree","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-820X","authenticated-orcid":true,"given":"Karen I.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"pdig.0000743.ref001","volume-title":"World Malaria Report 2023","author":"The World Health Organization","year":"2023"},{"key":"pdig.0000743.ref002","unstructured":"The World Health Organization. World Health Organization Malaria Threats Map. 2024."},{"issue":"6","key":"pdig.0000743.ref003","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","article-title":"Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda","volume":"223","author":"V Asua","year":"2021","journal-title":"J Infect Dis"},{"issue":"9","key":"pdig.0000743.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"PJ Rosenthal","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pdig.0000743.ref005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","article-title":"Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa","volume":"22","author":"PJ Rosenthal","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"pdig.0000743.ref006","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00109-24","article-title":"Artemisinin-resistant malaria","volume":"37","author":"NJ White","year":"2024","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"pdig.0000743.ref007","first-page":"2272","article-title":"Efficacy of dihydroartemisinin\/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam","volume":"75","author":"E Rovira-Vallbona","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"pdig.0000743.ref008","unstructured":"WHO. World Malaria Report. 2022."},{"key":"pdig.0000743.ref009","unstructured":"The World Health Organization. Strategy to respond to antimalarial drug resistance in Africa: Global Malaria Programme; 2022 [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240060265"},{"issue":"1","key":"pdig.0000743.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","article-title":"Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis","volume":"17","author":"Group WWARN K13 Genotype-Phenotype Study","year":"2019","journal-title":"BMC Med"},{"issue":"7481","key":"pdig.0000743.ref011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"F Ariey","year":"2014","journal-title":"Nature"},{"issue":"5","key":"pdig.0000743.ref012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"EA Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"pdig.0000743.ref013","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-10-339","article-title":"Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator","volume":"10","author":"JA Flegg","year":"2011","journal-title":"Malar J"},{"issue":"6","key":"pdig.0000743.ref014","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4269\/ajtmh.22-0148","article-title":"Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19","volume":"106","author":"PJ Rosenthal","year":"2022","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"pdig.0000743.ref015","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"A Uwimana","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"pdig.0000743.ref016","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00436-024-08203-3","article-title":"The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis","volume":"123","author":"DT Hung","year":"2024","journal-title":"Parasitol Res"},{"key":"pdig.0000743.ref017","doi-asserted-by":"crossref","first-page":"1366563","DOI":"10.3389\/fcimb.2024.1366563","article-title":"Detection of novel Plasmodium falciparum coronin gene mutations in a recrudescent ACT-treated patient in South-Western Nigeria","volume":"14","author":"O Ajibaye","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"pdig.0000743.ref018","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00249-4","article-title":"Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis","volume":"3","author":"FM Kagoro","year":"2022","journal-title":"Lancet Microbe"},{"issue":"1","key":"pdig.0000743.ref019","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12936-024-04981-4","article-title":"Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda","volume":"23","author":"C Schreidah","year":"2024","journal-title":"Malar J"},{"issue":"8","key":"pdig.0000743.ref020","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","article-title":"High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine","volume":"225","author":"J Straimer","year":"2022","journal-title":"J Infect Dis"},{"issue":"1","key":"pdig.0000743.ref021","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01299-23","article-title":"Escalating Plasmodium falciparum K13 marker prevalence indicative of artemisinin resistance in southern Rwanda","volume":"68","author":"W van Loon","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"pdig.0000743.ref022","article-title":"Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda","author":"MK Angwe","year":"2024","journal-title":"medRxiv"},{"issue":"3","key":"pdig.0000743.ref023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01818-18","article-title":"Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda","volume":"63","author":"V Asua","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pdig.0000743.ref024","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12936-024-04896-0","article-title":"Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021","volume":"23","author":"C Bakari","year":"2024","journal-title":"Malar J"},{"issue":"8","key":"pdig.0000743.ref025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa2211803","article-title":"Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda","volume":"389","author":"MD Conrad","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"pdig.0000743.ref026","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/infdis\/jiae288","article-title":"Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda","volume":"230","author":"S Tukwasibwe","year":"2024","journal-title":"J Infect Dis"},{"issue":"5","key":"pdig.0000743.ref027","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4269\/ajtmh.23-0382","article-title":"Screening for K13-Propeller Mutations Associated with Artemisinin Resistance in Plasmodium falciparum in Yambio County (Western Equatoria State, South Sudan)","volume":"109","author":"I Molina-de la Fuente","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"pdig.0000743.ref028","article-title":"Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study","author":"DS Ishengoma","year":"2024","journal-title":"medRxiv"},{"issue":"6","key":"pdig.0000743.ref029","doi-asserted-by":"crossref","DOI":"10.1111\/mec.17292","article-title":"Plasmodium falciparum transmission in the highlands of Ethiopia is driven by closely related and clonal parasites","volume":"33","author":"A Holzschuh","year":"2024","journal-title":"Mol Ecol"},{"issue":"1","key":"pdig.0000743.ref030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12936-023-04812-y","article-title":"Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia","volume":"23","author":"B Jeang","year":"2024","journal-title":"Malar J"},{"key":"pdig.0000743.ref031","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.actatropica.2016.02.007","article-title":"Molecular surveillance of antimalarial drug resistance related genes in Plasmodium falciparum isolates from Eritrea","volume":"157","author":"M Menegon","year":"2016","journal-title":"Acta Trop"},{"issue":"13","key":"pdig.0000743.ref032","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","article-title":"Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea","volume":"389","author":"S Mihreteab","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"pdig.0000743.ref033","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4269\/ajtmh.23-0740","article-title":"Detection of artemisinin resistance marker kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022","volume":"110","author":"W van Loon","year":"2024","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"pdig.0000743.ref034","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/tmi.13929","article-title":"Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies","volume":"28","author":"M Adam","year":"2023","journal-title":"Trop Med Int Health"},{"key":"pdig.0000743.ref035","unstructured":"Programme UNMC. Efficacy and Safety of Artemether-Lumefantrine, Pyronaridine-Artesunate, Artesunate-Amodiaquine, and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Children in Uganda. Unpublished. 2024."},{"key":"pdig.0000743.ref036","unstructured":"WHO. WHO Malaria Threats Map 2024 [Available from: https:\/\/apps.who.int\/malaria\/maps\/threats\/#\/"},{"issue":"9","key":"pdig.0000743.ref037","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00207-22","article-title":"Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017","volume":"66","author":"N Westercamp","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pdig.0000743.ref038","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4269\/ajtmh.21-0214","article-title":"Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial Resistance","volume":"105","author":"LF Moriarty","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"pdig.0000743.ref039","doi-asserted-by":"crossref","first-page":"102684","DOI":"10.1016\/j.tmaid.2023.102684","article-title":"Artemisinin resistance-associated gene mutations in Plasmodium falciparum: A case study of severe malaria from Mozambique","volume":"57","author":"D Casanova","year":"2024","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"pdig.0000743.ref040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3201\/eid2401.170864","article-title":"Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015","volume":"24","author":"H Gupta","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"pdig.0000743.ref041","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12936-020-3140-0","article-title":"Molecular surveillance of Pfcrt and k13 propeller polymorphisms of imported Plasmodium falciparum cases to Zhejiang Province, China between 2016 and 2018","volume":"19","author":"X Wang","year":"2020","journal-title":"Malar J"},{"key":"pdig.0000743.ref042","unstructured":"Eloff L A-DA, Routledge I, Chisenga M, Mangena B, Chimumbwa J, Sikaala C, et al. editor Preliminary Regional Results from GenE8. Annual Southern Africa Malaria Research Conference Conference 2024; 2024 31 July - 2 August; University of Pretoria."},{"issue":"13","key":"pdig.0000743.ref043","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of Artemisinin-Resistant Malaria in Africa","volume":"385","author":"B Balikagala","year":"2021","journal-title":"N Engl J Med"},{"key":"pdig.0000743.ref044","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","article-title":"A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa","volume":"16","author":"L Ndwiga","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"pdig.0000743.ref045","article-title":"High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing","author":"NW Young","year":"2024","journal-title":"medRxiv"},{"key":"pdig.0000743.ref046","doi-asserted-by":"crossref","unstructured":"Osoti V, Wamae K, Ndwiga L, Gichuki PF, Okoyo C, Kepha S. Detection of low-frequency artemisinin resistance mutations C469Y, P553L and A675V in asymptomatic primary school children in Kenya. 2024.","DOI":"10.21203\/rs.3.rs-5080885\/v1"},{"issue":"10","key":"pdig.0000743.ref047","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"A Uwimana","year":"2020","journal-title":"Nat Med"},{"issue":"25","key":"pdig.0000743.ref048","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms","volume":"374","author":"D M\u00e9nard","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pdig.0000743.ref049","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/mec.15706","article-title":"Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes","volume":"30","author":"KA Moser","year":"2021","journal-title":"Mol Ecol"},{"issue":"1","key":"pdig.0000743.ref050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12936-023-04517-2","article-title":"Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment","volume":"22","author":"JN Maniga","year":"2023","journal-title":"Malar J"},{"key":"pdig.0000743.ref051","doi-asserted-by":"crossref","unstructured":"Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D. Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania. medRxiv. 2023.","DOI":"10.1101\/2023.11.07.23298207"},{"issue":"8","key":"pdig.0000743.ref052","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01659-23","article-title":"Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda","volume":"68","author":"P Awor","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pdig.0000743.ref053","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3201\/eid2701.203527","article-title":"Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda","volume":"27","author":"C Bergmann","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"pdig.0000743.ref054","article-title":"Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda","author":"C Schreidah","year":"2023","journal-title":"medRxiv"},{"key":"pdig.0000743.ref055","doi-asserted-by":"crossref","unstructured":"Agaba BB, Travis J, Smith D, Rugera SP, Zalwango MG, Katureebe C. Emerging threat of partial artemisinin resistance markers in P. falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda. 2024.","DOI":"10.21203\/rs.3.rs-4248241\/v1"},{"issue":"1","key":"pdig.0000743.ref056","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","article-title":"Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda","volume":"13","author":"PK Tumwebaze","year":"2022","journal-title":"Nat Commun"},{"issue":"9753","key":"pdig.0000743.ref057","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial","volume":"376","author":"AM Dondorp","year":"2010","journal-title":"Lancet"},{"issue":"9487","key":"pdig.0000743.ref058","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"A Dondorp","year":"2005","journal-title":"Lancet"},{"key":"pdig.0000743.ref059","article-title":"Efficacy and safety of artemether-lumefantrine against uncomplicated falciparum malaria infection in Tanzania, 2022: a single-arm clinical trial","author":"JE Laury","year":"2024","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"pdig.0000743.ref060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12936-024-05019-5","article-title":"High prevalence and risk of malaria among asymptomatic individuals from villages with high prevalence of artemisinin partial resistance in Kyerwa district of Kagera region, north-western Tanzania","volume":"23","author":"SS Mandai","year":"2024","journal-title":"Malar J"},{"issue":"1","key":"pdig.0000743.ref061","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","article-title":"Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania","volume":"10","author":"GM Bwire","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"pdig.0000743.ref062","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01576-23","article-title":"A retrospective analysis of P. falciparum drug resistance markers detects an early (2016\/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda","volume":"68","author":"R Ogwang","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pdig.0000743.ref063","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01516-17","article-title":"Changing antimalarial drug sensitivities in Uganda","volume":"61","author":"SA Rasmussen","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"pdig.0000743.ref064","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"A Uwimana","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"pdig.0000743.ref065","first-page":"1048","volume-title":"A Method for Generating Dashboard Aggregations in an International HIV Consortium. MEDINFO 2021: One World, One Health\u2013Global Partnership for Digital Innovation","author":"JT Lewis","year":"2022"},{"key":"pdig.0000743.ref066","first-page":"238","volume-title":"Designing a dashboard for HIV-data reporting performance by Facilities: Case Study of Kenya. Advances in Informatics, Management and Technology in Healthcare","author":"M Gesicho","year":"2022"},{"key":"pdig.0000743.ref067","unstructured":"Roser M. Malaria: One of the leading causes of child deaths, but progress is possible and you can contribute to it. Our World in Data. 2024."},{"issue":"1","key":"pdig.0000743.ref068","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1186\/s12889-022-14657-w","article-title":"Evaluation of a public COVID-19 dashboard in the Western Cape, South Africa: a tool for communication, trust, and transparency","volume":"22","author":"M Ismail","year":"2022","journal-title":"BMC Public Health"},{"issue":"1","key":"pdig.0000743.ref069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41564-022-01276-9","article-title":"SARS-CoV-2 Africa dashboard for real-time COVID-19 information","volume":"8","author":"JS Xavier","year":"2023","journal-title":"Nat Microbiol"},{"key":"pdig.0000743.ref070","unstructured":"Africa MS. Antimalarial Drug Resistance Profile for Southern African Development Community Countries. 2025."},{"key":"pdig.0000743.ref071","unstructured":"Africa MS. Regional detailed action plan for responding to antimalarial drug resistance in East Africa. 2025."},{"key":"pdig.0000743.ref072","unstructured":"Africa MS. Antimalarial Drug Resistance Profile for the East African Community Countries. 2025."},{"key":"pdig.0000743.ref073","unstructured":"Africa MS. Unite for Action. 2025."},{"issue":"1","key":"pdig.0000743.ref074","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12936-021-03942-5","article-title":"Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa","volume":"20","author":"C Nsanzabana","year":"2021","journal-title":"Malar J"},{"issue":"9","key":"pdig.0000743.ref075","article-title":"Asymptomatic malaria in refugees living in a non-endemic South African city","volume":"9","author":"JM Tsoka-Gwegweni","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"pdig.0000743.ref076","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.EI10-0013-2016","article-title":"Artemisinin-Resistant Plasmodium falciparum Malaria","volume":"4","author":"RM Fairhurst","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"1","key":"pdig.0000743.ref077","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12936-019-2864-1","article-title":"High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia","volume":"18","author":"M Warsame","year":"2019","journal-title":"Malar J"},{"issue":"1","key":"pdig.0000743.ref078","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12936-019-2841-8","article-title":"Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial","volume":"18","author":"J Raman","year":"2019","journal-title":"Malar J"},{"issue":"3","key":"pdig.0000743.ref079","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00228-009-0750-4","article-title":"Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan","volume":"66","author":"SB Elamin","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"pdig.0000743.ref080","unstructured":"Efficacy and safety of artesunate amodiaquine with SLD of primaquine for treatment of falciparum malaria in Zanzibar."},{"issue":"8","key":"pdig.0000743.ref081","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3201\/eid2608.191547","article-title":"Increased Sensitivity of Plasmodium falciparum to Artesunate\/Amodiaquine Despite 14 Years as First-Line Malaria Treatment, Zanzibar","volume":"26","author":"M Msellem","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"pdig.0000743.ref082","unstructured":"Tjitra E. Artemisinin resistance and artemisinin-based combination therapy efficacy. 2018."},{"issue":"7","key":"pdig.0000743.ref083","doi-asserted-by":"crossref","DOI":"10.3201\/eid2707.203230","article-title":"Plasmodium falciparum kelch 13 mutations, 9 countries in Africa, 2014\u20132018","volume":"27","author":"SE Schmedes","year":"1902","journal-title":"Emerging Infectious Diseases"},{"key":"pdig.0000743.ref084","unstructured":"Angola NMCPo. Angola Guidelines and Standards of Conduct for Diagnosis and Treatment of Malaria 2014 In: Health NDoP, editor. 2014."},{"key":"pdig.0000743.ref085","unstructured":"Health TRoBMo. Guidelines for the Diagnosis and Treatment of Malaria in Botswana. In: Health Mo, editor. 2015."},{"key":"pdig.0000743.ref086","unstructured":"Programme NMC. Kenya malaria strategy 2019\u20132023. Ministry of Health Nairobi, Kenya; 2018."},{"key":"pdig.0000743.ref087","doi-asserted-by":"crossref","unstructured":"Nkoli PM, Moke DM, Kisita C, Kambala JPM, Kahunu GM, Tshala-Katumbay D. National guidelines for malaria treatment in Democratic Republic of the Congo: A critical appraisal. 2023.","DOI":"10.21203\/rs.3.rs-2856584\/v1"},{"key":"pdig.0000743.ref088","unstructured":"Republic of Mozambique MoH. Strategic plan for malarai control in Mozambique. In: National Directorate of Health NMCP, editor. 2006."},{"key":"pdig.0000743.ref089","unstructured":"Rwanda Ro. Rwanda Integrated Malaria Control Guidelines. In: Health Mo, editor. 2024."},{"key":"pdig.0000743.ref090","unstructured":"Department of Health RoSA. National Guidelines for the Treatment of Malaria, South Africa 2018. 2018."},{"key":"pdig.0000743.ref091","unstructured":"Zambia MoHTo. National Malaria Elimination Strategic Plan 2022-2026. 2022."},{"key":"pdig.0000743.ref092","unstructured":"Health UMo. Circular on Updated Guidelines for the treatment of malaria. In: Division NMC, editor. 2022."},{"key":"pdig.0000743.ref093","unstructured":"Ministry of Health TURoT, Nationa Malaria Control Programme. National Guidelines for Malaria Diagnosis, Treatment and Preventative Therapies. 2020."},{"issue":"2","key":"pdig.0000743.ref094","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform"}],"updated-by":[{"DOI":"10.1371\/journal.pdig.0001596","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000}}],"container-title":["PLOS Digital Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pdig.0000743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:36:31Z","timestamp":1778088991000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pdig.0000743"}},"subtitle":[],"editor":[{"given":"Louise A C","family":"Millard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":94,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pdig.0000743","relation":{},"ISSN":["2767-3170"],"issn-type":[{"value":"2767-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}